.
BioEnterprise

Xellia Pharmaceuticals, FDA Reach Agreement on How to Revive Former Ben Venue Complex

Xellia Pharmaceuticals has entered into an agreement with the U.S. Food and Drug Administration that could allow the company to bring the former Ben Venue Laboratories complex back to life.

Read More  >